Repligen Corp’s filing revealed that its Director Hunt Anthony unloaded Company’s shares for reported $3.27 million on May 15 ’25. In the deal valued at $123.71 per share,26,447 shares were sold. As a result of this transaction, Hunt Anthony now holds 109,854 shares worth roughly $12.29 million.
Then, Hunt Anthony bought 26,447 shares, generating $3,394,208 in total proceeds.
Before that, Hunt Anthony sold 26,756 shares. Repligen Corp shares valued at $4,080,663 were divested by the Director at a price of $152.51 per share. As a result of the transaction, Hunt Anthony now holds 136,301 shares, worth roughly $15.25 million.
A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late June with a ‘”an Overweight”‘ rating. Wolfe Research also remained covering RGEN and has increased its forecast on April 29, 2025 with a “an Outperform” recommendation from previously “Peer perform” rating. Evercore ISI started covering the stock on March 18, 2025. It rated RGEN as “an In-line”.
Price Performance Review of RGEN
On Monday, Repligen Corp [NASDAQ:RGEN] saw its stock jump 0.40% to $111.88. Over the last five days, the stock has lost -3.97%. Repligen Corp shares have fallen nearly -31.15% since the year began. Nevertheless, the stocks have fallen -22.27% over the past one year. While a 52-week high of $182.52 was reached on 01/28/25, a 52-week low of $102.96 was recorded on 04/07/25.
Levels Of Support And Resistance For RGEN Stock
The 24-hour chart illustrates a support level at 111.08, which if violated will result in even more drops to 110.28. On the upside, there is a resistance level at 112.83. A further resistance level may holdings at 113.78.
How much short interest is there in Repligen Corp?
A steep rise in short interest was recorded in Repligen Corp stocks on 2025-07-15, growing by 7266.0 shares to a total of 3.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 3.39 million shares. There was a rise of 0.21%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 10, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating along with a $200 price target.
